The plasma donor is the first vital part of the process to produce safe and effective plasma protein therapeutics, and the industry prioritizes the safety and health of its plasma donors.
Although venomous snakebites are rare in the U.S. compared to other countries, they are still medical emergencies that need to be treated with today’s safe and effective methods.
A physician diagnoses the condition and either treats it or refers the patient to someone else for treatment. End of story. Or is that just the beginning of the story? Narrative medicine challenges the medical model by bringing a new tool to the table: the story of the patient.
Screening and new treatments offer a high cure rate for those affected by hepatitis C, which was once a grave disease.
Although noncommunicable diseases are the leading cause of morbidity and mortality in most developed nations, zoonotic diseases remain a major public health concern.
As it has since the first commercially produced factor VIII concentrate transformed the lives of U.S. hemophilia A patients, innovation is still the life-blood of this industry.
An ongoing revolution in healthcare ties data and reimbursement with the demand for analytics that provide insight into a variety of areas.
Changes are needed in the way scientific research is currently conducted to ensure its legitimacy and efficacy.
Explore the history and trace the development of BabyBIG, the life-saving immunotherapy for infant botulism.
Government and researchers continue to pursue plans and studies to gain a greater understanding of this devastating and deadly disease in order to prevent, treat and, ultimately, cure it.
Statin-triggered autoimmune myopathy can occur in rare instances where muscle-related symptoms fail to resolve following stoppage of the medication.
An exploratory controlled, randomized, double-blind study was conducted by investigators at the Sutter Neuroscience Institute in Sacramento to determine whether a single course of
intravenous immune globulin (IVIG) influences the rate of brain atrophy and cognitive function in mild cognitive impairment (MCI) due to Alzheimer’s disease (AD).
